Company: BNBX
Filing Date: 2025-01-17
Form Type: 424B3
Source: 0001104659-25-004510
Chunk: 50

Company: BNB PLUS CORP.
Filing Date: 2025-01-17
Form: 424B3
Chunk 50
---
 provided, however, that we are not incorporating
any information furnished under Item 2.02 or Item 7.01 of any current report on Form 8-K:

| · |     | The                                                                                                                         
 description of our capital stock contained in our registration statement on Form 8-A                                        
 (File No. 001-36745) filed with the Commission on November 13, 2014, pursuant                                               
 to Section 12(b) of the Exchange Act, including any amendment or report filed for the purpose of updating such description. |

Upon written or oral request, we will provide
without charge to each person, including any beneficial owner, to whom a copy of the prospectus is delivered a copy of the documents
incorporated by reference in this prospectus (other than exhibits to such documents unless such exhibits are specifically incorporated
by reference in this prospectus). You may request a copy of these filings, at no cost, by writing or telephoning us at the following
address: Applied DNA Sciences, Inc., 50 Health Sciences Drive, Stony Brook, New York 11790, c/o Investor Relations, telephone: 631-240-8800. You may
also access these documents on our website at www.adnas.com.

Information on our website, including subsections, pages, or other
subdivisions of our website, or any website linked to by content on our website, is not part of this prospectus and you should not rely
on that information unless that information is also in this prospectus or incorporated by reference in this prospectus.

<div align='center'>23

Up to 20,312,500 shares of Common Stock underlying the Series C Warrants

Up to 20,312,500 shares of Common Stock underlying the Series D Warrants

Up to 1,015,625 shares of Common Stock underlying the Placement Agent Warrants

Applied DNA Sciences, Inc.

PROSPECTUS

January 17, 2025</div>